Seven Eight Capital’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-108,389
Closed -$2.07M 439
2024
Q3
$2.07M Buy
108,389
+54,241
+100% +$1.12M 0.19% 172
2024
Q2
$1.12M Buy
+54,148
New +$1.08M 0.12% 320
2024
Q1
Sell
-16,752
Closed -$242K 754
2023
Q4
$242K Buy
16,752
+6,696
+67% +$91.1K 0.03% 559
2023
Q3
$175K Sell
10,056
-11,045
-52% -$230K 0.02% 564
2023
Q2
$439K Buy
21,101
+4,506
+27% +$97.9K 0.07% 337
2023
Q1
$390K Buy
+16,595
New +$446K 0.08% 284
2022
Q3
Sell
-7,265
Closed -$245K 587
2022
Q2
$245K Buy
+7,265
New +$254K 0.1% 293

Other funds holding OGN

Seven Eight Capital's OGN Position: Q4 2024 in Review

Seven Eight Capital sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 108,389 shares — an estimated $2.07M sold.

Seven Eight Capital first reported a position in OGN in Q2 2022 and held it in 7 quarters. The position peaked at $2.07M in Q3 2024. 738 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

  • Seven Eight Capital reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
  • Seven Eight Capital sold 108,389 Organon & Co shares in Q4 2024, an estimated $2.07M.
  • Seven Eight Capital first reported a position in Organon & Co in Q2 2022 and held it in 7 quarters.
  • Seven Eight Capital's Organon & Co position peaked at $2.07M in Q3 2024.
  • 738 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on Seven Eight Capital's 13F filing for Q4 2024.